{"text": ["Wednesday", "Sector", "Laggards:", "Utilities,", "Healthcare"], "created_at": "2019-06-26 20:07:55"}
{"text": ["Wednesday", "Sector", "Laggards:", "Utilities,", "Healthcare"], "created_at": "2019-06-26 20:07:55"}
{"text": ["Lilly's", "Heart", "Drug", "Snags", "Fast", "Track", "Designation;", "Type", "2", "Diabetes", "Drug", "Found", "Effective", "At", "Higher", "Doses"], "created_at": "2019-06-26 14:22:07"}
{"text": ["The", "Daily", "Biotech", "Pulse:", "Decision", "Day", "For", "Regeneron-Sanofi,", "Vermillion", "Offering,", "PDL", "BioPharma", "CFO", "to", "Depart"], "created_at": "2019-06-26 11:19:56"}
{"text": ["Lilly's", "AWARD-11", "trial", "studying", "higher", "investigational", "doses", "of", "Trulicity\u00ae", "(dulaglutide)", "demonstrated", "superiority", "in", "A1C", "reduction", "in", "people", "with", "type", "2", "diabetes"], "created_at": "2019-06-26 10:45:00"}
{"text": ["U.S.", "FDA", "Grants", "Fast", "Track", "Designation", "to", "Empagliflozin", "for", "the", "Treatment", "of", "Chronic", "Heart", "Failure"], "created_at": "2019-06-26 10:00:00"}
